Illumina, Boehringer Ingelheim to develop companion diagnostics for oncology products
As part of the first programme, the companies will develop a CDx for a Boehringer Ingelheim investigational medicine
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jan 22
As part of the first programme, the companies will develop a CDx for a Boehringer Ingelheim investigational medicine
11 Jan 22
Beginning this month, the Galleri test will be offered to eligible patients through the OHSU Knight Cancer Institute
11 Jan 22
The LiquidHALLMARK assay, powered by AmpliMark, is in use nationwide and offers improved fusion detection by complementing DNA…
10 Jan 22
The new test kits consist of CE-IVD certified SARS-CoV-2 and Delta variant kit, and research use only (RUO)…
10 Jan 22
PreventionGenetics offers more than 5,000 predefined genetic tests for approximately all clinically relevant genes and additional custom panels
07 Jan 22
The new single-plex assay is expected to help clinicians and researchers in delivering better-informed treatment and containment decisions…
07 Jan 22
OMX is a metabolomics test that gives practitioners a deeper understanding of their patients' metabolic function and reveals…
06 Jan 22
Hologic launched the GAI at the 2018 International AIDS Conference with a breakthrough all-inclusive pricing structure
03 Jan 22
The new nasal swab test, which will help rapidly detect SARS-CoV-2, has the potential to deliver test results…
03 Jan 22
The company has been working with Idaho Molecular and Advanced Conceptions for the development of its upcoming at-home…